FLAP - Immune System Research

AZD5718 is an Orally Active Inhibitor of FLAP (5‑Lipoxygenase Activating Protein)

5-Lipoxygenase-activating protein (FLAP) is essential for cellular leukotriene synthesis. FLAP is the target of leukotriene biosynthesis inhibitors. The 5-lipoxygenase pathway is responsible for the production of leukotrienes, lipid mediators derived…

Peritonitis

Diflapolin is a Highly Active dual FLAP and sEH Inhibitor

Edward Jenner 2021-01-26

The arachidonic acid (AA) cascade plays a central role in the biosynthesis of lipid mediators (LMs) with anti-inflammatory properties cascade plays an important role in the biosynthesis of lipid mediators…

AZD5718 is an Orally Active Inhibitor of FLAP (5‑Lipoxygenase Activating Protein)

Diflapolin is a Highly Active dual FLAP and sEH Inhibitor

You Missed

Mirikizumab is a Humanized IgG4 mAb for Ulcerative Colitis Research

Grazoprevir is a Hepatitis C virus NS3/4A Protease Inhibitor for Infection Research

Efbemalenograstim alfa is a Recombinant Fusion Protein for Neutropenia Research

Remibrutinib is an Orally Active BTK Inhibitor for Chronic Urticaria Research